Stock Events

Stock Events

Orgenesis 

$0.002100
27
-$0.04-95.5%Friday 19:01

Statistics

Day High
0.91
Day Low
0.91
52W High
0.91
52W Low
0.0004
Volume
100
Avg. Volume
997
Mkt Cap
20,580
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 11Expected
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q4 2025
Next
-2.3
-0.7
0.9
2.5
Expected EPS
N/A
Actual EPS
N/A

Financials

-10,445.47%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
530,000Revenue
-55.36MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ORGS. It's not an investment recommendation.
NVIDIA
4
NVDA
Apple
3
AAPL
Microsoft
3
MSFT
Realty Income
3
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.36B
CRISPR Therapeutics is involved in gene editing, a direct competitor to Orgenesis's cell and gene therapy technologies.
Intellia Therapeutics
NTLA
Mkt Cap1.72B
Intellia Therapeutics is a leading gene editing company using CRISPR/Cas9 technology, competing in the gene therapy sector.
Editas Medicine
EDIT
Mkt Cap402.38M
Editas Medicine operates in the CRISPR gene editing space, making it a direct competitor to Orgenesis's gene therapy efforts.
Pfizer
PFE
Mkt Cap158.45B
Pfizer has a growing portfolio in gene therapy, making it a competitor to Orgenesis, especially in commercialization and development.
Biomarin Pharmaceutical
BMRN
Mkt Cap11.07B
BioMarin Pharmaceutical focuses on enzyme replacement therapies and has ventured into gene therapy, competing with Orgenesis.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences, through its acquisition of Kite Pharma, competes in the cell therapy space, particularly in cancer, which is a focus for Orgenesis.

About

Orgenesis Inc. is a global biotechnology firm dedicated to the field of cell and gene therapies. The company has engineered an innovative Point of Care (POCare) platform. This system incorporates a portfolio of licensed POCare therapeutics, which are manufactured and prepared using automated, self-contained POCare technology within a cooperative network. Orgenesis primarily concentrates on autologous therapies, developing customized processes and systems for each treatment. These utilize a closed, automated processing methodology, validated for safe and compliant production directly at the patient's location, facilitating immediate therapeutic application. Established in 2008 as Business Outsourcing Service, Inc., the company adopted the name Orgenesis Inc. in August 2011 and is headquartered in Germantown, Maryland.
Show More
CEO
Vered Caplan
Employees
77
Country
United States
ISIN
US68619K3032
WKN
000A40PUK

Listings

STU
DE
45O0.STU
OTC Link
US
ORGS

0 Comments

Share your thoughts

FAQs

What is Orgenesis stock price today?▼
The current price of ORGS is $0.00 USD — it has decreased by -95.5% in the past 24 hours. Watch Orgenesis stock price performance more closely on the chart.
What is Orgenesis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Orgenesis stocks are traded under the ticker ORGS.
Is Orgenesis stock price growing?▼
ORGS stock has fallen by -99.48% compared to the previous week, the month change is a -99.62% fall, over the last year Orgenesis has showed a -98.6% decrease.
What is Orgenesis market cap?▼
Today Orgenesis has the market capitalization of 20,580
When is the next Orgenesis earnings date?▼
Orgenesis is going to release the next earnings report on November 11, 2026.
What is Orgenesis revenue for the last year?▼
Orgenesis revenue for the last year amounts to 530,000 USD.
What is Orgenesis net income for the last year?▼
ORGS net income for the last year is -55.36M USD.
How many employees does Orgenesis have?▼
As of November 1, 2026, the company has 77 employees.
In which sector is Orgenesis located?▼
Orgenesis operates in the Health & Wellness sector.
When did Orgenesis complete a stock split?▼
The last stock split for Orgenesis was on September 25, 2024 with a ratio of 1:10.
Where is Orgenesis headquartered?▼
Orgenesis is headquartered in Germantown, United States.